Fund Secured: MediWounds' CEO Ofer Gonen in Conversation with PharmaShots

By PharmaShots

Shots: Ofer Gonen, CEO at MediWound, in conversation with PharmaShots, sheds light on recent funding from the US Department of Defence to further develop NexoBrid for the US Army NexoBrid an FDA-approved enzymatic therapy to treat severe burns is jointly developed b

You are viewing a robot-friendly page.Click hereto reload in standard format.